Theratechnologies, Inc. (TH.TO)
4.47
0.00 (0.00%)
CAD |
TSX |
Oct 02, 16:00
Theratechnologies Net Income (Quarterly) : -6.276M for May 31, 2025
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2025 | -6.276M |
| February 28, 2025 | 0.1675M |
| November 30, 2024 | -10.87M |
| August 31, 2024 | 4.232M |
| May 31, 2024 | 1.345M |
| February 29, 2024 | -6.026M |
| November 30, 2023 | -3.762M |
| August 31, 2023 | -0.9945M |
| May 31, 2023 | -13.59M |
| February 28, 2023 | -14.09M |
| November 30, 2022 | -10.70M |
| August 31, 2022 | -9.730M |
| May 31, 2022 | -28.90M |
| February 28, 2022 | -11.48M |
| November 30, 2021 | -12.44M |
| August 31, 2021 | -11.84M |
| May 31, 2021 | -7.928M |
| February 28, 2021 | -7.550M |
| November 30, 2020 | -7.309M |
| August 31, 2020 | -9.091M |
| May 31, 2020 | -8.126M |
| February 29, 2020 | -5.988M |
| November 30, 2019 | -8.536M |
| August 31, 2019 | -2.167M |
| May 31, 2019 | -4.254M |
| Date | Value |
|---|---|
| February 28, 2019 | -1.635M |
| November 30, 2018 | -1.293M |
| August 31, 2018 | 0.367M |
| May 31, 2018 | -2.46M |
| February 28, 2018 | -2.627M |
| November 30, 2017 | -4.216M |
| August 31, 2017 | -2.882M |
| May 31, 2017 | -9.109M |
| February 28, 2017 | -2.243M |
| November 30, 2016 | 0.173M |
| August 31, 2016 | 0.888M |
| May 31, 2016 | -0.498M |
| February 29, 2016 | -0.153M |
| November 30, 2015 | 0.488M |
| August 31, 2015 | 1.179M |
| May 31, 2015 | 0.818M |
| February 28, 2015 | -0.914M |
| November 30, 2014 | -3.62M |
| August 31, 2014 | -4.394M |
| May 31, 2014 | 1.007M |
| February 28, 2014 | -3.534M |
| November 30, 2013 | -2.598M |
| August 31, 2013 | -1.935M |
| May 31, 2013 | -1.382M |
| February 28, 2013 | 1.86M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Spectral Medical, Inc. | 0.331M |
| Resverlogix Corp. | -8.421M |
| COSCIENS Biopharma, Inc. | -0.2796M |
| Restart Life Sciences Corp. | -1.017M |
| Covalon Technologies Ltd. | 2.811M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 24.93M |
| Total Expenses (Quarterly) | 31.21M |
| EPS Diluted (Quarterly) | -0.1271 |